Evaluation of Pulsatile Tinnitus with Syncope in an Elderly Patient
The next critical step is prolonged ambulatory ECG monitoring with an external loop recorder or implantable loop recorder to capture the cardiac rhythm during syncopal episodes, as the combination of pulsatile tinnitus and recurrent syncope strongly suggests an occult arrhythmia that requires rhythm-symptom correlation for definitive diagnosis. 1
Primary Diagnostic Priority: Arrhythmia Detection
The clinical presentation demands urgent focus on cardiac arrhythmia evaluation despite the negative structural workup:
Recurrent syncope (2-3 episodes over 9 months) in an elderly patient with diabetes represents a high-risk scenario requiring aggressive arrhythmia surveillance, even when initial cardiac imaging is unremarkable 1
The gold standard for diagnosing arrhythmic syncope is ECG documentation of the rhythm disturbance at the time of symptoms 1
For symptoms occurring every few weeks to months (as in this case), an implantable loop recorder is specifically recommended and provides diagnostic information in >90% of patients with unexplained syncope 1
If an implantable device is not immediately feasible, a 14-30 day external loop recorder is appropriate for relatively frequent symptoms, with median time to first arrhythmia detection of 1.0 days 2, 3
Why Pulsatile Tinnitus Matters Here
The pulsatile tinnitus ("whooshing sound" synchronous with heartbeat) is a critical clue that has likely been under-appreciated:
This symptom suggests either vascular pathology OR intermittent tachyarrhythmias that the patient perceives as pulsatile sensations 1
While vascular causes (carotid stenosis, AAA) have been appropriately excluded, the combination with syncope shifts probability heavily toward paroxysmal arrhythmia 1
The sensation of heartbeat in abdomen, head, and ears during episodes may represent the patient's perception of rapid heart rates during supraventricular or ventricular tachycardia 1
Specific Monitoring Strategy
Based on symptom frequency (episodes every few months), the monitoring approach should be:
First-Line Option:
- Implantable loop recorder for 12-14 months of continuous monitoring 1, 4
- This is cost-effective and has superior diagnostic yield compared to conventional Holter or electrophysiological testing 1, 4
- Particularly indicated given the "malignant" nature of her syncope (recurrent episodes with injury risk) 1
Alternative if Implantable Device Unavailable:
- Extended external loop recorder (14-30 days) with automatic and patient-activated triggers 2, 3
- 93% of arrhythmias are captured within 2 months of monitoring 2
- Higher diagnostic yield (63.2%) than traditional 24-48 hour Holter monitoring 3
Additional Concurrent Evaluation
While awaiting arrhythmia monitoring results:
Carotid Sinus Massage
- Specifically recommended for unexplained syncope in patients >60 years old 1
- Should be performed in controlled environment with ECG recording and resuscitation equipment available 1
- Risk of neurologic adverse events is <1 in 1000, but informed consent required 1
Orthostatic Vital Signs
- Assess for orthostatic hypotension, particularly given diabetes (autonomic neuropathy risk) 1
- Measure blood pressure supine and after 1 and 3 minutes of standing 1
Critical Pitfalls to Avoid
Do not assume vasovagal syncope or pursue tilt-table testing as the next step 1:
- Tilt testing is NOT recommended as first-line investigation for unexplained syncope 1
- Even with negative tilt test, most likely diagnosis remains neurocardiogenic syncope, making the test low-yield 1
- In elderly patients with recurrent syncope, arrhythmia exclusion takes absolute priority 1
Do not order electroencephalography 1:
- Brief seizure activity can occur during syncope itself (convulsive syncope) 1
- The negative CT head and MRA already exclude structural neurologic causes 1
- Inappropriate EEG use may lead to misdiagnosis of epilepsy 1
Do not delay monitoring while awaiting cardiology consultation 1:
- The pending arrhythmia evaluation should proceed urgently given recurrent syncope 1
- Each syncopal episode carries risk of injury or sudden death if due to malignant arrhythmia 1
Why Electrophysiological Study is NOT the Next Step
- Electrophysiological testing has low yield (approximately 3%) in patients without structural heart disease 1
- The patient's TTE was unremarkable, placing her in the "normal cardiac evaluation" category 1
- EP study is reserved for patients with structural heart disease or after negative prolonged monitoring in high-risk cases 1
Prognosis Context
- In the absence of structural heart disease, syncope is not associated with excess mortality, but carries significant injury risk 1
- The main danger is physical harm from recurrent episodes, making definitive diagnosis essential 1
- If arrhythmia is identified, specific treatment (pacing for bradycardia, ablation for tachycardia) can be curative 1